Genetic & Genomic MedicineeLifePeer-reviewed
JAK inhibition decreases the autoimmune burden in Down syndrome
Angela L. Rachubinski, Elizabeth B. Wallace, Emily Gurnee…·Joaquin Maximiliano Espinosa
This study investigates immune dysregulation in Down syndrome and shows that JAK inhibition with tofacitinib reduces autoimmune symptoms and inflammatory markers without significant adverse effects.
9 citations